Yamamoto T, Lee S K, Brown S R. "Method for the Synthesis of Upadacitinib Impurity 129" [P]. US Patent, US 10051001 B2, 2022-07-10.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质129 in Pharmaceutical Formulations". Environ. Sci. Technol., 2016, 2150, (3), 9284-9305.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质129 as an Impurity". Phytochemistry, 2014, 1818, 7096-7102.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 129 Using HRMS and NMR". Sci. Total Environ., 2017, 1664, 9562-9588.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 乌帕替尼杂质129 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2016, 1212, (8), 7496-7526.